Tarbox Family Office’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-147
Closed -$1K 1146
2020
Q2
$1K Hold
147
﹤0.01% 900
2020
Q1
$2K Buy
+147
New +$1.84K ﹤0.01% 599

Other funds holding ANGO

Tarbox Family Office's ANGO Position: Q3 2020 in Review

Tarbox Family Office sold out of AngioDynamics (ANGO) in Q3 2020, closing a stake of 147 shares — an estimated $1K sold.

Tarbox Family Office first reported a position in ANGO in Q1 2020 and held it in 2 quarters. The position peaked at $2K in Q1 2020. 138 funds tracked by Wall St. Rank hold ANGO as of Q3 2020.

  • Tarbox Family Office reported no remaining AngioDynamics position as of Q3 2020 after selling out during the quarter.
  • Tarbox Family Office sold 147 AngioDynamics shares in Q3 2020, an estimated $1K.
  • Tarbox Family Office first reported a position in AngioDynamics in Q1 2020 and held it in 2 quarters.
  • Tarbox Family Office's AngioDynamics position peaked at $2K in Q1 2020.
  • 138 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2020.

Based on Tarbox Family Office's 13F filing for Q3 2020, filed 22 Oct 2020.